NCT00561730

Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)

Pantoprazole 20 mg/40 mg for the Treatment of Gastroesophageal Reflux Disease (GERD)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,995 (actual)
• Sponsor: Nycomed · Industry
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

The aim of the study was to evaluate the effect of 7 days treatment with Pantoprazole 40 mg and 20 mg on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) in clinical practice. During the study, the patients had to complete a short version of a patient-orientated, self-assessed reflux questionnaire (ReQuest™ in Practice).

Conditions

• Gastroesophageal Reflux Disease

Interventions

Type	Name	Description
DRUG	Pantoprazole	Observational, non-interventional study (NIS). The physician decided about dosage according to individual needs (20 or 40 mg pantoprazole, once daily).

Timeline

• Start date: 2007-10-01
• Completion: 2008-12-01
• First posted: 2007-11-21
• Last updated: 2012-05-08
• Results posted: 2010-09-16

Locations

259 sites across 1 country: Germany